Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Transmucosal Drug Delivery market report explains the definition, types, applications, major countries, and major players of the Transmucosal Drug Delivery market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Acrux Limited
Antares Pharma Inc
ALZA Corporation
Corium International Inc
tesa Labtec GmbH
Mylan Inc
Apricus BioSciences Inc
Inovio Pharmaceuticals Inc
Nemaura Pharma Ltd
MedPharm LTD
Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
Nitto Denko Corporation
Zosano Pharma
3M Pharmaceuticals
DURECT Corporation
TEVA Pharmaceutical Industries Ltd
Aveva Drug Delivery Systems
Tapemark
Generex Biotechnology Corporation
Pantec Biosolutions AG
Noven Pharmaceuticals Inc
By Type:
Passive Transdermal Drug Delivery
Active Transdermal Drug Delivery
By End-User:
Hospital
Clinic
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Transmucosal Drug Delivery Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Transmucosal Drug Delivery Outlook to 2028- Original Forecasts
-
2.2 Transmucosal Drug Delivery Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Transmucosal Drug Delivery Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Transmucosal Drug Delivery Market- Recent Developments
-
6.1 Transmucosal Drug Delivery Market News and Developments
-
6.2 Transmucosal Drug Delivery Market Deals Landscape
7 Transmucosal Drug Delivery Raw Materials and Cost Structure Analysis
-
7.1 Transmucosal Drug Delivery Key Raw Materials
-
7.2 Transmucosal Drug Delivery Price Trend of Key Raw Materials
-
7.3 Transmucosal Drug Delivery Key Suppliers of Raw Materials
-
7.4 Transmucosal Drug Delivery Market Concentration Rate of Raw Materials
-
7.5 Transmucosal Drug Delivery Cost Structure Analysis
-
7.5.1 Transmucosal Drug Delivery Raw Materials Analysis
-
7.5.2 Transmucosal Drug Delivery Labor Cost Analysis
-
7.5.3 Transmucosal Drug Delivery Manufacturing Expenses Analysis
8 Global Transmucosal Drug Delivery Import and Export Analysis (Top 10 Countries)
-
8.1 Global Transmucosal Drug Delivery Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Transmucosal Drug Delivery Export by Region (Top 10 Countries) (2017-2028)
9 Global Transmucosal Drug Delivery Market Outlook by Types and Applications to 2022
-
9.1 Global Transmucosal Drug Delivery Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Active Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
9.2 Global Transmucosal Drug Delivery Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Transmucosal Drug Delivery Market Analysis and Outlook till 2022
-
10.1 Global Transmucosal Drug Delivery Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Transmucosal Drug Delivery Consumption (2017-2022)
-
10.2.2 Canada Transmucosal Drug Delivery Consumption (2017-2022)
-
10.2.3 Mexico Transmucosal Drug Delivery Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Transmucosal Drug Delivery Consumption (2017-2022)
-
10.3.2 UK Transmucosal Drug Delivery Consumption (2017-2022)
-
10.3.3 Spain Transmucosal Drug Delivery Consumption (2017-2022)
-
10.3.4 Belgium Transmucosal Drug Delivery Consumption (2017-2022)
-
10.3.5 France Transmucosal Drug Delivery Consumption (2017-2022)
-
10.3.6 Italy Transmucosal Drug Delivery Consumption (2017-2022)
-
10.3.7 Denmark Transmucosal Drug Delivery Consumption (2017-2022)
-
10.3.8 Finland Transmucosal Drug Delivery Consumption (2017-2022)
-
10.3.9 Norway Transmucosal Drug Delivery Consumption (2017-2022)
-
10.3.10 Sweden Transmucosal Drug Delivery Consumption (2017-2022)
-
10.3.11 Poland Transmucosal Drug Delivery Consumption (2017-2022)
-
10.3.12 Russia Transmucosal Drug Delivery Consumption (2017-2022)
-
10.3.13 Turkey Transmucosal Drug Delivery Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Transmucosal Drug Delivery Consumption (2017-2022)
-
10.4.2 Japan Transmucosal Drug Delivery Consumption (2017-2022)
-
10.4.3 India Transmucosal Drug Delivery Consumption (2017-2022)
-
10.4.4 South Korea Transmucosal Drug Delivery Consumption (2017-2022)
-
10.4.5 Pakistan Transmucosal Drug Delivery Consumption (2017-2022)
-
10.4.6 Bangladesh Transmucosal Drug Delivery Consumption (2017-2022)
-
10.4.7 Indonesia Transmucosal Drug Delivery Consumption (2017-2022)
-
10.4.8 Thailand Transmucosal Drug Delivery Consumption (2017-2022)
-
10.4.9 Singapore Transmucosal Drug Delivery Consumption (2017-2022)
-
10.4.10 Malaysia Transmucosal Drug Delivery Consumption (2017-2022)
-
10.4.11 Philippines Transmucosal Drug Delivery Consumption (2017-2022)
-
10.4.12 Vietnam Transmucosal Drug Delivery Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Transmucosal Drug Delivery Consumption (2017-2022)
-
10.5.2 Colombia Transmucosal Drug Delivery Consumption (2017-2022)
-
10.5.3 Chile Transmucosal Drug Delivery Consumption (2017-2022)
-
10.5.4 Argentina Transmucosal Drug Delivery Consumption (2017-2022)
-
10.5.5 Venezuela Transmucosal Drug Delivery Consumption (2017-2022)
-
10.5.6 Peru Transmucosal Drug Delivery Consumption (2017-2022)
-
10.5.7 Puerto Rico Transmucosal Drug Delivery Consumption (2017-2022)
-
10.5.8 Ecuador Transmucosal Drug Delivery Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Transmucosal Drug Delivery Consumption (2017-2022)
-
10.6.2 Kuwait Transmucosal Drug Delivery Consumption (2017-2022)
-
10.6.3 Oman Transmucosal Drug Delivery Consumption (2017-2022)
-
10.6.4 Qatar Transmucosal Drug Delivery Consumption (2017-2022)
-
10.6.5 Saudi Arabia Transmucosal Drug Delivery Consumption (2017-2022)
-
10.6.6 United Arab Emirates Transmucosal Drug Delivery Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Transmucosal Drug Delivery Consumption (2017-2022)
-
10.7.2 South Africa Transmucosal Drug Delivery Consumption (2017-2022)
-
10.7.3 Egypt Transmucosal Drug Delivery Consumption (2017-2022)
-
10.7.4 Algeria Transmucosal Drug Delivery Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Transmucosal Drug Delivery Consumption (2017-2022)
-
10.8.2 New Zealand Transmucosal Drug Delivery Consumption (2017-2022)
11 Global Transmucosal Drug Delivery Competitive Analysis
-
11.1 Acrux Limited
-
11.1.1 Acrux Limited Company Details
-
11.1.2 Acrux Limited Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Acrux Limited Transmucosal Drug Delivery Main Business and Markets Served
-
11.1.4 Acrux Limited Transmucosal Drug Delivery Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Antares Pharma Inc
-
11.2.1 Antares Pharma Inc Company Details
-
11.2.2 Antares Pharma Inc Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Antares Pharma Inc Transmucosal Drug Delivery Main Business and Markets Served
-
11.2.4 Antares Pharma Inc Transmucosal Drug Delivery Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 ALZA Corporation
-
11.3.1 ALZA Corporation Company Details
-
11.3.2 ALZA Corporation Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 ALZA Corporation Transmucosal Drug Delivery Main Business and Markets Served
-
11.3.4 ALZA Corporation Transmucosal Drug Delivery Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Corium International Inc
-
11.4.1 Corium International Inc Company Details
-
11.4.2 Corium International Inc Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Corium International Inc Transmucosal Drug Delivery Main Business and Markets Served
-
11.4.4 Corium International Inc Transmucosal Drug Delivery Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 tesa Labtec GmbH
-
11.5.1 tesa Labtec GmbH Company Details
-
11.5.2 tesa Labtec GmbH Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 tesa Labtec GmbH Transmucosal Drug Delivery Main Business and Markets Served
-
11.5.4 tesa Labtec GmbH Transmucosal Drug Delivery Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Mylan Inc
-
11.6.1 Mylan Inc Company Details
-
11.6.2 Mylan Inc Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Mylan Inc Transmucosal Drug Delivery Main Business and Markets Served
-
11.6.4 Mylan Inc Transmucosal Drug Delivery Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Apricus BioSciences Inc
-
11.7.1 Apricus BioSciences Inc Company Details
-
11.7.2 Apricus BioSciences Inc Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Apricus BioSciences Inc Transmucosal Drug Delivery Main Business and Markets Served
-
11.7.4 Apricus BioSciences Inc Transmucosal Drug Delivery Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Inovio Pharmaceuticals Inc
-
11.8.1 Inovio Pharmaceuticals Inc Company Details
-
11.8.2 Inovio Pharmaceuticals Inc Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Inovio Pharmaceuticals Inc Transmucosal Drug Delivery Main Business and Markets Served
-
11.8.4 Inovio Pharmaceuticals Inc Transmucosal Drug Delivery Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Nemaura Pharma Ltd
-
11.9.1 Nemaura Pharma Ltd Company Details
-
11.9.2 Nemaura Pharma Ltd Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Main Business and Markets Served
-
11.9.4 Nemaura Pharma Ltd Transmucosal Drug Delivery Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 MedPharm LTD
-
11.10.1 MedPharm LTD Company Details
-
11.10.2 MedPharm LTD Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 MedPharm LTD Transmucosal Drug Delivery Main Business and Markets Served
-
11.10.4 MedPharm LTD Transmucosal Drug Delivery Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
-
11.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details
-
11.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Main Business and Markets Served
-
11.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Nitto Denko Corporation
-
11.12.1 Nitto Denko Corporation Company Details
-
11.12.2 Nitto Denko Corporation Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Nitto Denko Corporation Transmucosal Drug Delivery Main Business and Markets Served
-
11.12.4 Nitto Denko Corporation Transmucosal Drug Delivery Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Zosano Pharma
-
11.13.1 Zosano Pharma Company Details
-
11.13.2 Zosano Pharma Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Zosano Pharma Transmucosal Drug Delivery Main Business and Markets Served
-
11.13.4 Zosano Pharma Transmucosal Drug Delivery Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 3M Pharmaceuticals
-
11.14.1 3M Pharmaceuticals Company Details
-
11.14.2 3M Pharmaceuticals Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 3M Pharmaceuticals Transmucosal Drug Delivery Main Business and Markets Served
-
11.14.4 3M Pharmaceuticals Transmucosal Drug Delivery Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 DURECT Corporation
-
11.15.1 DURECT Corporation Company Details
-
11.15.2 DURECT Corporation Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 DURECT Corporation Transmucosal Drug Delivery Main Business and Markets Served
-
11.15.4 DURECT Corporation Transmucosal Drug Delivery Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 TEVA Pharmaceutical Industries Ltd
-
11.16.1 TEVA Pharmaceutical Industries Ltd Company Details
-
11.16.2 TEVA Pharmaceutical Industries Ltd Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 TEVA Pharmaceutical Industries Ltd Transmucosal Drug Delivery Main Business and Markets Served
-
11.16.4 TEVA Pharmaceutical Industries Ltd Transmucosal Drug Delivery Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Aveva Drug Delivery Systems
-
11.17.1 Aveva Drug Delivery Systems Company Details
-
11.17.2 Aveva Drug Delivery Systems Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Main Business and Markets Served
-
11.17.4 Aveva Drug Delivery Systems Transmucosal Drug Delivery Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Tapemark
-
11.18.1 Tapemark Company Details
-
11.18.2 Tapemark Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Tapemark Transmucosal Drug Delivery Main Business and Markets Served
-
11.18.4 Tapemark Transmucosal Drug Delivery Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Generex Biotechnology Corporation
-
11.19.1 Generex Biotechnology Corporation Company Details
-
11.19.2 Generex Biotechnology Corporation Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Main Business and Markets Served
-
11.19.4 Generex Biotechnology Corporation Transmucosal Drug Delivery Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Pantec Biosolutions AG
-
11.20.1 Pantec Biosolutions AG Company Details
-
11.20.2 Pantec Biosolutions AG Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Pantec Biosolutions AG Transmucosal Drug Delivery Main Business and Markets Served
-
11.20.4 Pantec Biosolutions AG Transmucosal Drug Delivery Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 Noven Pharmaceuticals Inc
-
11.21.1 Noven Pharmaceuticals Inc Company Details
-
11.21.2 Noven Pharmaceuticals Inc Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 Noven Pharmaceuticals Inc Transmucosal Drug Delivery Main Business and Markets Served
-
11.21.4 Noven Pharmaceuticals Inc Transmucosal Drug Delivery Product Portfolio
-
11.21.5 Recent Research and Development Strategies
12 Global Transmucosal Drug Delivery Market Outlook by Types and Applications to 2028
-
12.1 Global Transmucosal Drug Delivery Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Active Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Transmucosal Drug Delivery Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Transmucosal Drug Delivery Market Analysis and Outlook to 2028
-
13.1 Global Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.2.2 Canada Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.2.3 Mexico Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.2 UK Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.3 Spain Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.4 Belgium Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.5 France Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.6 Italy Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.7 Denmark Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.8 Finland Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.9 Norway Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.10 Sweden Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.11 Poland Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.12 Russia Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.13 Turkey Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.2 Japan Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.3 India Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.4 South Korea Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.8 Thailand Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.9 Singapore Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.11 Philippines Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.5.2 Colombia Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.5.3 Chile Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.5.4 Argentina Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.5.6 Peru Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.6.3 Oman Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.6.4 Qatar Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.7.2 South Africa Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.7.3 Egypt Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.7.4 Algeria Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Transmucosal Drug Delivery Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Transmucosal Drug Delivery Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Transmucosal Drug Delivery
-
Figure of Transmucosal Drug Delivery Picture
-
Table Global Transmucosal Drug Delivery Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Transmucosal Drug Delivery Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Global Active Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Transmucosal Drug Delivery Consumption by Country (2017-2022)
-
Table North America Transmucosal Drug Delivery Consumption by Country (2017-2022)
-
Figure United States Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Canada Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Mexico Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table Europe Transmucosal Drug Delivery Consumption by Country (2017-2022)
-
Figure Germany Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure UK Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Spain Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Belgium Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure France Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Italy Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Denmark Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Finland Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Norway Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Sweden Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Poland Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Russia Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Turkey Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table APAC Transmucosal Drug Delivery Consumption by Country (2017-2022)
-
Figure China Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Japan Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure India Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure South Korea Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Thailand Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Singapore Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Philippines Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table South America Transmucosal Drug Delivery Consumption by Country (2017-2022)
-
Figure Brazil Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Colombia Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Chile Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Argentina Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Peru Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table GCC Transmucosal Drug Delivery Consumption by Country (2017-2022)
-
Figure Bahrain Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Oman Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Qatar Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table Africa Transmucosal Drug Delivery Consumption by Country (2017-2022)
-
Figure Nigeria Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure South Africa Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Egypt Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Algeria Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table Oceania Transmucosal Drug Delivery Consumption by Country (2017-2022)
-
Figure Australia Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Transmucosal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table Acrux Limited Company Details
-
Table Acrux Limited Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acrux Limited Transmucosal Drug Delivery Main Business and Markets Served
-
Table Acrux Limited Transmucosal Drug Delivery Product Portfolio
-
Table Antares Pharma Inc Company Details
-
Table Antares Pharma Inc Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Antares Pharma Inc Transmucosal Drug Delivery Main Business and Markets Served
-
Table Antares Pharma Inc Transmucosal Drug Delivery Product Portfolio
-
Table ALZA Corporation Company Details
-
Table ALZA Corporation Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table ALZA Corporation Transmucosal Drug Delivery Main Business and Markets Served
-
Table ALZA Corporation Transmucosal Drug Delivery Product Portfolio
-
Table Corium International Inc Company Details
-
Table Corium International Inc Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Corium International Inc Transmucosal Drug Delivery Main Business and Markets Served
-
Table Corium International Inc Transmucosal Drug Delivery Product Portfolio
-
Table tesa Labtec GmbH Company Details
-
Table tesa Labtec GmbH Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table tesa Labtec GmbH Transmucosal Drug Delivery Main Business and Markets Served
-
Table tesa Labtec GmbH Transmucosal Drug Delivery Product Portfolio
-
Table Mylan Inc Company Details
-
Table Mylan Inc Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Inc Transmucosal Drug Delivery Main Business and Markets Served
-
Table Mylan Inc Transmucosal Drug Delivery Product Portfolio
-
Table Apricus BioSciences Inc Company Details
-
Table Apricus BioSciences Inc Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Apricus BioSciences Inc Transmucosal Drug Delivery Main Business and Markets Served
-
Table Apricus BioSciences Inc Transmucosal Drug Delivery Product Portfolio
-
Table Inovio Pharmaceuticals Inc Company Details
-
Table Inovio Pharmaceuticals Inc Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Inovio Pharmaceuticals Inc Transmucosal Drug Delivery Main Business and Markets Served
-
Table Inovio Pharmaceuticals Inc Transmucosal Drug Delivery Product Portfolio
-
Table Nemaura Pharma Ltd Company Details
-
Table Nemaura Pharma Ltd Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nemaura Pharma Ltd Transmucosal Drug Delivery Main Business and Markets Served
-
Table Nemaura Pharma Ltd Transmucosal Drug Delivery Product Portfolio
-
Table MedPharm LTD Company Details
-
Table MedPharm LTD Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table MedPharm LTD Transmucosal Drug Delivery Main Business and Markets Served
-
Table MedPharm LTD Transmucosal Drug Delivery Product Portfolio
-
Table Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details
-
Table Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Main Business and Markets Served
-
Table Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product Portfolio
-
Table Nitto Denko Corporation Company Details
-
Table Nitto Denko Corporation Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nitto Denko Corporation Transmucosal Drug Delivery Main Business and Markets Served
-
Table Nitto Denko Corporation Transmucosal Drug Delivery Product Portfolio
-
Table Zosano Pharma Company Details
-
Table Zosano Pharma Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zosano Pharma Transmucosal Drug Delivery Main Business and Markets Served
-
Table Zosano Pharma Transmucosal Drug Delivery Product Portfolio
-
Table 3M Pharmaceuticals Company Details
-
Table 3M Pharmaceuticals Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table 3M Pharmaceuticals Transmucosal Drug Delivery Main Business and Markets Served
-
Table 3M Pharmaceuticals Transmucosal Drug Delivery Product Portfolio
-
Table DURECT Corporation Company Details
-
Table DURECT Corporation Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table DURECT Corporation Transmucosal Drug Delivery Main Business and Markets Served
-
Table DURECT Corporation Transmucosal Drug Delivery Product Portfolio
-
Table TEVA Pharmaceutical Industries Ltd Company Details
-
Table TEVA Pharmaceutical Industries Ltd Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table TEVA Pharmaceutical Industries Ltd Transmucosal Drug Delivery Main Business and Markets Served
-
Table TEVA Pharmaceutical Industries Ltd Transmucosal Drug Delivery Product Portfolio
-
Table Aveva Drug Delivery Systems Company Details
-
Table Aveva Drug Delivery Systems Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aveva Drug Delivery Systems Transmucosal Drug Delivery Main Business and Markets Served
-
Table Aveva Drug Delivery Systems Transmucosal Drug Delivery Product Portfolio
-
Table Tapemark Company Details
-
Table Tapemark Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tapemark Transmucosal Drug Delivery Main Business and Markets Served
-
Table Tapemark Transmucosal Drug Delivery Product Portfolio
-
Table Generex Biotechnology Corporation Company Details
-
Table Generex Biotechnology Corporation Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Generex Biotechnology Corporation Transmucosal Drug Delivery Main Business and Markets Served
-
Table Generex Biotechnology Corporation Transmucosal Drug Delivery Product Portfolio
-
Table Pantec Biosolutions AG Company Details
-
Table Pantec Biosolutions AG Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pantec Biosolutions AG Transmucosal Drug Delivery Main Business and Markets Served
-
Table Pantec Biosolutions AG Transmucosal Drug Delivery Product Portfolio
-
Table Noven Pharmaceuticals Inc Company Details
-
Table Noven Pharmaceuticals Inc Transmucosal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Noven Pharmaceuticals Inc Transmucosal Drug Delivery Main Business and Markets Served
-
Table Noven Pharmaceuticals Inc Transmucosal Drug Delivery Product Portfolio
-
Figure Global Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Active Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Transmucosal Drug Delivery Consumption Forecast by Country (2022-2028)
-
Table North America Transmucosal Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure United States Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Transmucosal Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure Germany Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Transmucosal Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure China Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Transmucosal Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure Brazil Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Transmucosal Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Transmucosal Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Transmucosal Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure Australia Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Transmucosal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
